13 research outputs found

    MPTP-Treated Zebrafish Recapitulate ā€˜Late-Stageā€™ Parkinsonā€™s-like Cognitive Decline

    Full text link
    The zebrafish is a promising model species in biomedical research, including neurotoxicology and neuroactive drug screening. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) evokes degeneration of dopaminergic neurons and is commonly used to model Parkinsonā€™s disease (PD) in laboratory animals, including zebrafish. However, cognitive phenotypes in MPTP-evoked experimental PD models remain poorly understood. Here, we established an LD50 (292 mg/kg) for intraperitoneal MPTP administration in adult zebrafish, and report impaired spatial working memory (poorer spontaneous alternation in the Y-maze) in a PD model utilizing fish treated with 200 Āµg of this agent. In addition to conventional behavioral analyses, we also employed artificial intelligence (AI)-based approaches to independently and without bias characterize MPTP effects on zebrafish behavior during the Y-maze test. These analyses yielded a distinct cluster for 200-Āµg MPTP (vs. other) groups, suggesting that high-dose MPTP produced distinct, computationally detectable patterns of zebrafish swimming. Collectively, these findings support MPTP treatment in adult zebrafish as a late-stage experimental PD model with overt cognitive phenotypes. Ā© 2022 by the authors. Licensee MDPI, Basel, Switzerland.Funding: The experiments were implemented using the equipment and unique scientific installation ā€œBiological collectionā€“Genetic biomodels of neuropsychiatric disordersā€ (No. 493387) of the Federal State Budgetary Scientific Institution ā€œScientific Research Institute of Neurosciences and Medicineā€ theme no. AAAA-A21-121011990039-2 (2021ā€“2025). The study partially used the facilities and equipment of the Resource Fund of Applied Genetics MIPT (support grant 075-15-2021-684)

    Apoptosis and apoptotic extracellular vesicular particles in atherogenesis

    No full text
    The review summarizes current notions on the role of apoptosis and apoptotic cell-derived extracellular vesicles in atherogenesis. The mechanisms of efferocytosis impairment and its significance in atherosclerotic vulnerable plaque formation are discussed. The data on the pro- and anti-inflammatory effects of apoptotic extracellular vesicular particles are presented
    corecore